Literature DB >> 2670574

The utility of the panic disorder concept.

D F Klein1, H M Klein.   

Abstract

In this paper we discuss the theory that agoraphobic avoidances are central and spontaneous panics an epiphenomenon to the development of agoraphobia. Moreover we discuss the theory that posits a fixed cognitive-catastrophizing set as causal for panic. We conclude these theories do not fit the facts. We argue that it is important to distinguish between spontaneous panic and chronic or anticipatory anxiety and avoidance. Such a distinction allows for an understanding of the roles of anti-spontaneous panic medications such as tricyclics and MAOI's as well as exposure therapy, in the treatment of panic disorder with agoraphobia. The former serves the purpose of blocking panic attacks while the latter undermines phobic avoidance, but only after the panic attacks have ceased through proper medication. We conclude that recognizing the key role of spontaneous panic and its variants in anxiety nosology is a necessary guide for etiological, psychophysiological and therapeutic research in this rapidly developing area.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2670574     DOI: 10.1007/bf00449808

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Neurol Sci        ISSN: 0175-758X


  82 in total

1.  Ventilatory physiology of patients with panic disorder.

Authors:  J M Gorman; M R Fyer; R Goetz; J Askanazi; M R Liebowitz; A J Fyer; J Kinney; D F Klein
Journal:  Arch Gen Psychiatry       Date:  1988-01

2.  Importance of psychiatric diagnosis in prediction of clinical drug effects.

Authors:  D F Klein
Journal:  Arch Gen Psychiatry       Date:  1967-01

3.  Panic disorder: residual symptoms after the acute attacks abate.

Authors:  W Katon; P P Vitaliano; K Anderson; M Jones; J Russo
Journal:  Compr Psychiatry       Date:  1987 Mar-Apr       Impact factor: 3.735

4.  Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias.

Authors:  D V Sheehan; J Davidson; T Manschreck; J Van Wyck Fleet
Journal:  J Clin Psychopharmacol       Date:  1983-02       Impact factor: 3.153

5.  Temporal relationship between panic attack onset and phobic avoidance in agoraphobia.

Authors:  B A Thyer; J Himle
Journal:  Behav Res Ther       Date:  1985

6.  Genetic factors in anxiety disorders.

Authors:  S Torgersen
Journal:  Arch Gen Psychiatry       Date:  1983-10

7.  The Zurich Study. V. Anxiety and phobia in young adults.

Authors:  J Angst; A Dobler-Mikola
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

8.  A family study of generalized anxiety disorder.

Authors:  R Noyes; C Clarkson; R R Crowe; W R Yates; C M McChesney
Journal:  Am J Psychiatry       Date:  1987-08       Impact factor: 18.112

9.  Treatment of agoraphobia with group exposure in vivo and imipramine.

Authors:  C M Zitrin; D F Klein; M G Woerner
Journal:  Arch Gen Psychiatry       Date:  1980-01

10.  Clinical and pharmacokinetic factors affecting response to phenelzine.

Authors:  P Tyrer; M Gardner; J Lambourn; M Whitford
Journal:  Br J Psychiatry       Date:  1980-04       Impact factor: 9.319

View more
  3 in total

1.  Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?

Authors:  W Maier; S M Roth; N Argyle; R Buller; P Lavori; S Brandon; O Benkert
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

2.  Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.

Authors:  W Maier; R Rosenberg; N Argyle; R Buller; M Roth; S Brandon; O Benkert
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

3.  Antianxiety medications for the treatment of complex agoraphobia: pharmacological interventions for a behavioral condition.

Authors:  Giampaolo Perna; Silvia Daccò; Roberta Menotti; Daniela Caldirola
Journal:  Neuropsychiatr Dis Treat       Date:  2011-10-19       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.